NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: migraine

10/11/2018

Doctor’s $620,000 conflict of interest not disclosed in Inquirer story on new migraine drugs

4/23/2018

Reuters numbs with numbers on experimental migraine drug

12/18/2017

Philadelphia Inquirer story skirts discussion of evidence for experimental migraine drug

9/29/2016

STAT’s look at migraine drugs in development skimmed over key research details

5/14/2015

Bold claims for migraine treatment are based on opinions and anecdote in this story

3/3/2015

Nerve Treatment Via Nose Shows Promise Against Migraines

1 1/23/2013

FDA Approves 1st Skin Patch to Combat Migraines

4/25/2012

Preventive medicines can help migraine sufferers

4/25/2012

Experts issue new guidelines for preventing migraines with drugs

4/24/2012

Surgery for migraines: Help or hokum?